
Feng Runhua
Job TitleDeputy Chief PhysicianDepartment普外科

Good At
Surgical operation and individualized comprehensive treatment of gastrointestinal and thyroid tumors.
Introduction
Feng Runhua, male, deputy chief physician, MD, majoring in surgery, School of Medicine, Shanghai Jiao Tong University, and a "Pujiang Talent" in Shanghai City. Served as a fellow member of the American Society of Oncology Surgeons (SSO), a fellow member of the American Society for Clinical Oncology (ASCO), and a fellow member of the American Association for Cancer Research (AACR) and a fellow member of the International Association for Gastric Cancer (IGCA). He has long been engaged in clinical work in gastrointestinal and thyroid tumor surgery, and is proficient in developing various new minimally invasive surgical techniques. 2012-2015 In 1999, as a "McCarthy Research Fellow", a "Senior Visiting Scientist" was awarded a number of awards at the best cancer hospital in the United States: M.D. Anderson Cancer Center (M.D. Anderson Cancer Center)"Oncology Surgery" carries out surgical clinical work and has established good cooperative relationships with American oncology surgery experts. He specializes in minimally invasive surgical treatment and individualized comprehensive treatment of gastrointestinal tumors and thyroid tumors, and advocates efficient treatment concepts. Pursue excellence and strive for excellence in surgery. The completed cases have achieved many good results in domestic competitions, and the treatment level has reached the first-class domestic level. In addition, it is the first in China to carry out perioperative comprehensive treatments such as intraoperative intraperitoneal hyperthermic perfusion chemotherapy (HIPEC), neoadjuvant intraperitoneal and systemic combined chemotherapy (NIPS), and neoadjuvant chemotherapy combined with immunotherapy for gastrointestinal malignancies, which are improving the degree of radical surgery for gastrointestinal tumors, preventing and treating postoperative peritoneal metastasis and recurrence, and improving patients 'quality of life.




